AU639928B2 - Sequential degradation of peptides - Google Patents

Description

OPI DATE 10/12/91 APPLN. ID 56737 PCI AOJP DATE 16/01/92 PCT NUMBER PCT/US90/02723 INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (51) International Patent Classification 5 (11) International Publication Number: WO 91/18008 C07K 1/10 Al (43) International Publication Date: 28 November 1991 (28.11.91) (21) International Application Number: PCT/US90/02723 Published With international search report.

(22) International Filing Date: 18 May 1990 (18.05.90) (71) Applicant (for all designated States except US): CITY OF HOPE [US/US]; 1500 East Duarte Road, Duarte, CA 91010 (US).

(72) Inventor; and 6 3 9 Inventor/Applicant (for US only) BAILEY, Jerome, M.

[US/US]; 3362 Fish Canyon Road, Duarte, CA 91010

(US).

(74) Agent: IRONS, Edward, 919 18th Street, N.W. #800, Washington, DC 2000C (US).

(81) Designated States: AT (European patent), AU, BE (European patent), CA, CH (European patent), DE (European patent)*, DK (Earopean patent), ES (European patent), FR (European patent), GB (European patent), IT (European patent), JP, KR, LU (European patent), NL (European patent), SE (European patent), US.

(54) Title: SEQUENTIAL C-TERMINAL DEGRADATION OF PEPTIDES AND PROTEINS (57) Abstract Alkali metal trimethylsilanolates are described for use as cleavage reagents in carboxy terminal protein sequencing.

See back of page j WO 91/18008 PCT/US90/02723 -1- SEQUENTIAL C-TERMINAL DEGRADATION OF PEPTIDES AND PROTEINS Field of the Invention This invention relates to the sequential degradation of peptides and proteins from the carboxy-terminus. More particularly, the invention relates to a method for the cleavage of the C-terminal thiohydantoin amino acid from the derivatized peptide which results from the use of a silylisothiocyanate as a coupling reagent in carboxy-terminal sequencing procedures.

Background of the Invention A. Background The development of methods for the sequential degradation of proteins and peptides from the carboxy-terminus has been the objective of several studies. See Ward, Practical Protein Chemistry A Handbook (Darbre, ed.) (1986) and Rangarajan, Protein/Peptide Sequence Analysis: Current (1988). Such a method would complement existing N-terminal degradations based on the Edman chemistry. Edman, Acta.Chem.Scand. 4:283-293 (1950). The most widely studied method and probably the most attractive because of its similarity to the Edman degradation has been the conversion of amino acids into thiohydantoins. This reaction, originally observed by Johnson and Nicolet, J.Am.Chem.Soc.

33:1973-1978 (1911), was first applied to the sequential degradation of proteins from the carboxy-terminus by Schlack and Kumpf, Z.Physiol.Chem. 154:125-170 (1926). These authors reacted ammonium thiocyanate, dissolved in acetic Li WO 91/

I

ii :j i i ii i i t

I

i i'i j '18008 PCT/US90/02723 acid and acetic anhydride, with N-benzoylated peptides to form carboxyl-terminal l-acyl-2-thiohydantoins. Exposure to strong base was used to liberate the amino acid thiohydantoin and generate a new carboxyl-terminal amino acid. The main disadvantages of this procedure have been the severity of the conditions required for complete derivatization of the C-terminal amino acid and for the subsequent cleavage of the peptidylthiohydantoin derivative into a new shortened peptide and an amino acid thiohydantoin derivative.

Since this work was published, numerous groups have tried to reduce the severity of the conditions required, particularly in the cleavage of the peptidylthiohydantoin, in order to apply this chemistry to the sequential degradation of proteins from the carboxyl terminal end. Lesser concentrations of sodium hydroxide than originally used by Schlack and Kumpf and of barium hydroxide were found to effectively cleave peptidylthiohydantoins. See Waley, et al., J.Chem.Soc. 1951:2394-2397 (1951); Kjaer, et al., Acta Chem.Scand. 6:448-450 (1952); Turner, et al., Biochim.Biophys.Acta. 13:553-559 (1954). Other groups used acidic conditions based on the original procedure used by Johnson and Nicolet for the de-acetylation of amino acid thiohydantoins. See Tibbs, Nature 168:910 (1951); Baptist, et al., J.Am.Chem.Soc. 75:1727-1729 (1953). These authors added concentrated hydrochloric acid to the coupling solution to cause cleavage of the peptidylthiohydantoin bond. Unlike hydroxide which was shown to cause breakdown of the thiohydantoin amino acids, hydrochloric acid was shown not to destroy the amino acid thiohydantoins. See Scoffone, et al., Ric.Sci. 26:865-871 (1956); Fox, et al., J.Am.Chem. Soc. 77:3119-3122 (1955); Stark, Biochem. 7:1796-1807 (1968). Cromwell, L.D., T4 i- WO 91/18008 PCT/US90/02723 -3et al., Biochem. 8:4735-4740 (1969) showed that the concentrated hydrochloric acid could be used to cleave the thiohydantoin amino acid at room temperature. The major drawback with this procedure was that when applied to proteins, no more than two or three cycles could be performed.

Yamashita, Biochem.Biophys.Acta. 229:301-309 (1971) found that cleavage of peptidylthiohydantoins could be done in a repetitive manner with a protonated cation exchange resin. Application of this procedure to 100 pmol quantities of papain and ribonuclease was reported to give 14 and 10 cycles, respectively, although no details were given. See Yamashita, et al., Proc.Hoshi.Pharm. 13:136-138 (1971). Stark reported that certain organic bases, such as morpholine or piperidine, could be substituted for sodium hydroxide, and along the same lines, Kubo, et al., Chem.Pharm.Bull. 19:210-211 (1971) reported that aqueous triethylamine could be used to effectively cleave pen-tidylthiohydantoins. Stark appeared to have solved the cleavage problem by introducing acetohydroxamic acid in aqueous pyridine at pH 8.2 as a cleavage reagent. This reagent was shown to rapidly and specifically cleave i peptidylthiohydantoins at room temperature and at mild pH.

i Conditions for the formulation of the peptidylthiohydantoins were improved by Stark and Dwulet, et al., Int.J.Peptide and Protein Res.

13:122-129 (1979), who reported on the use of thiocyanic acid rather than thiocyanate salts, and more recently by the introduction of trimethylsilylisothiocyanate (TMS-ITC) as a coupling reagent. See Hawke, et al., Anal.Biochem.

166:298-307 (1987). The use of this reagent for C-terminal sequencing has been patented. See Hawke patent United States 4,837,165. This reagent WO 91/18008 PCT/US90/02723 I-4- Isignificantly improved the yields of peptidylthiohydantoin formation and reduced the Snumber of complicating side products. Cleavage of peptidylthiohydantoins by 12 N HC1 (Hawke, 1987) and I by acetohydroxamate (Miller, et al., Techniques I in Protein Chemistry (Hugli, ed.) pp. 67-68, Academic Press (1989)) failed to yield more than a i few cycles of degradation.

I B. The Cleavage Problem Although the cleavage reaction has been extensively studied since the thiocyanate chemistry for C-terminal degradation was first proposed by I Schlack and Kumpf in 1926, a chemical method has not yet been proposed that is capable of an extended degradation. Cleavage in lN sodium hydroxide as i first proposed by Schlack and Kumpf (1926) is well known to hydrolyze proteins and peptides at other i sites in addition to cleavage of the C-terminal peptidylthiohydantoin. The released thiohydantoin amino acid derivatives are also known to be unstable in hydroxide solutions. Scoffone, supra. Cleavage Sby hydroxide is known to convert the side chain amide i groups of asparagine and glutamine residues to a carboxylic group making these residues i indistinguishable from aspartate and glutamate, respectively.

When cleavage of peptidylthiohydantoins by 12N i HC1 was applied to proteins and peptides no more than 2 or 3 cycles could be performed. See, Cromwell, supra and Hawke, supra. This was probably due to differences in the rate of hydrolysis of peptidylthiohydantoins containing different amino acid side chains as well as to hydrolysis of other internal amide bonds. Likewise, during the synthesis of the standard amino acid thiohydantoin derivatives corresponding to the naturally occurring amino acids, it was observed that the rate of deacetylation of the N-acetylthiohydantoin amino acids by 12 HC1 depended 1 I ICI WO 91/18008 PCU/US90/02723 on the nature of the amino acid side chain. Bailey, et al. Biochem. 29:3145-3156 (.990).

Attempts by Dwulet, supra, to reproduce the resin based cleavage method of Yamashita, supra, was reported to be unsuccessful. Cleavage of peptidylthiohydantoins with aqueous methanesulfonic i acid was also attempted by Dwulet and by Bailey, et i al., both without success. Methanesulfonic acid was chosen since it is equivalent to the acidic group on i the resin employed by Yamashita (1971) and Yamashita, et al. (1971).

i Cleavage of the peptidylthiohydantoin derivatives with acetohydroxamate as originally reported by Stark, supra, was found to result in the formation of Sstable hydroxamate esters at the C-terminus of the shortened peptide (Bailey, et al., supra). Depending on the conditions employed, between 68% and 93% of the peptide was derivatized at the C-terminus and thus prevented from further sequencing. Althoucrh Stark, supra, predicted such hydroxamate esters 'o form as an intermediate during cleavage, it was iassumed that they would break down under the conditions used for cleavage or continued i sequencing. The peptidyl hydroxamate esters formed from cleavage with acetohydroxamate, like the hydroxamate esters studied by Stieglitz, et al., J.Am.Chem.Soc. 36:272-301 (1914) and Scott, et al., J.Am.Chem.Soc. 49:2545-2549 (1927), are stable under the acidic conditions used for thiohydantoin formation and can only be hydrolyzed to a free peptidyl carboxylic group, capable of continued sequencing, under strongly basic conditions. This probably explains the low repetitive yields of Stark, supra; Meuth, et al., Biochem. 21:3750-3757 (1982) and Miller, supra, when aqueous acetohydroxamate was employed as a cleavage reagent.

1 WO 91/18008 PCT/US90/02723 -6- Cleavage of peptidylthiohydantoins by aqueous triethylamine was originally reported by Kubo, et al., Chem.Pharm.Bull. 19:210-211 (1971), Dwulet, et al., supra, and Meuth, et al., supra. The latter group commented on the usefulness of triethylamine as a cleavage reagent for automated sequencing because of its volatility, but declined to pursue this method apparently in favor of cleavage by acetohydroxamate.

Cleavage of peptidylthiohydantoins, in the solution phase, by a 2% aqueous solution of triethylamine was found to be rapid (half-times of 1 min. and 5 min. at 37*C and 22*C, respectively) and quantitative, yielding only shortened peptide capable of continued sequencing and the amino acid thiohydantoin derivative. Bailey, et al., supra.

Summary of the Invention This invention provides a novel cleavage reagent, specifically an alkali metal salt of a lower trialkylsilanol, for use in the carboxy terminal peptide sequencing prccedure. The novel cleavage reagent has particular utility in, but is not limited to, sequencing procedures in which a silyl isothiocyanate is used as the coupling reagent. Sodium trimethylsilanolate is preferred. Also, in the preferred practice of the invention, the peptide sample is covalently coupled to a polyvinyldifluoride (PVDF).

Detailed Description of the Invention The mechanism of acid and base hydrolysis of acylthiohydantoins was studied in detail by Congdon and Edward, Can.J.Chem. 50:3767-3788 (1972) and a number of cleavage reagents were tested by Stark, supra. Stark found that oxygen containing nucleophiles were the best choice of reagents to effect this reaction. Although acetohydrox©mate is an excellent cleavage reagent for the first amino acid, it forms a stable peptidyl hydroxamate ester, L i WO 91/18008 PCT/US90/02723 -7which is difficult to remove, and which effectively blocks the shortened peptide from further sequencing. This reagent also results in a high UV absorbing background during subsequent HPLC identification of the released thiohydantoin amino acids. It seems that in general any carbon based reagent that is a good nucleophi-e and thus a good cleavage reagent will also be a poor leaving group, thereby blocking much of the shortened peptide from further sequencing.

Ideally, a cleavage reagent should possess the following characteristics: it should be able to cleave peptidylthiohydantoins in a volatile, water i miscible organic solvent, thus eliminating the problems of incompatibility of PVDF membranes with water; the reaction should be rapid and specific; the shortened peptide should be capable of continued degradation; the released thiohydantoin 1 amino acid should not be destroyed by this reagent; i and this reagent should not absorb light in the same range as is used for detection of the released thiohydantoin amino acid derivatives. Sodium trimethylsilanolate (Figure commercially available from Petrarch (Huls), in alcoholic solvents seems to possess all of these characteristics.

i Cleavage of peptidylthiohydantoins in the solution phase with a 0.05M solution of sodium trimethylki silanolate in 100% methanol or trimethylsilylethanol is complete in less than 5 minutes. A 0.05M solution of sodium trimethylsilanolate in methanol or trirethylsilylethanol effects cleavage of peptidylthiohydantoins both in the solution phase and in the solid phase in less than 5 minutes.

More specifically, this invention contemplates the use of the cleavage reagents of this invention in a concentration of from about 0.025 molar to about 0.25 molar, preferably from about 0.1 to about 0.2 molar, in methanol, trimethylsilylethanol or similar alcohols.

WO91/18008 PCT/US90/02723 -8- The most probable mechanism of this cleavage involves formation of an unstable C-terminal trimethylsilyl ester which, in the presence of water or alcohol, rapidly reforms the desired C-terminal carboxylic group (Figure 2).

Figure 2 illustrates the use of aqueous trifluoroacetic acid (TFA) following the cleavage reaction. Preferably, the concentration of TFA in i this step is from about 0.01M to about 0.2M. The use of TFA or an equivalent acid at this stage significantly facilitates cleavage.

Standard techniques are utilized for coupling the peptide to PVDF or to another membrane. A PVDF Smembrane or the like of appropriate size is placed in the continuous flow reactor described in Shively, Serial No. 07/072,754, filed July 13, 1987 and activated by treatment for about two hours with 2 pL of 1,3-dicyclohexylcarbodiimide (2 mM/mL) in N,N-dimethylformamide (DMF). The activated membrane is washed with two mL of DMF and dried under a stream i of argon. The peptide sample in solution in DMF is Slayered on the dry membrane and allowed to react overnight. The membrane is then washed with methanol i and dried under a stream of argon.

j Use of this new reagent for cleavage in i trimethylsilylethanol as a solvent has allowed the automated C-terminal sequencing of four cycles, each l for both YGGFL and KVILF covalently coupled to PVDF.

The fifth residue, Y and K, respectively, could not be sequenced as this is the residue which is used for covalently attaching the peptides to the PVDF.

Although trimethylsilyl ethanol is a good solvent for cleavage, it may not be an ideal solvent because of its high boiling point and insolubility with water.

Other alcoholic solvents useful in the invention include alkanols having from one to about four atoms, methanol, ethanol, isopropnIol and trimethylsilylmethanol.

WO 91/18008 PCT/US90/02723 -9- In its more broad aspects, the invention includes cleavage reagents having the formula R 3 Sio-X in which R is a straight or branched chain hydrocarbon radical having from about 1 to about 10 carbon atoms and X is an alkali metal ion, preferably a sodium or a potassium ion.

p Exemplification of the Invention The examples described herein illustrate C-terminal sequencing accomplished with a modified N-terminal sequencer based on the design of Hawke, et al., Anal.Biochem. 147:315-330 (1985), in which a continuous flow reactor as described in Shively i United States patent application Serial No. 072,754 was utilized. Release of thiohydantoin amino acids was detected by an on-line HPLC. See Shively, Anal.Biochem. 163:517-529 (1987). The reagent and solvent delivery system were all constructed from perfluoroelastomers. Delivery valves as generally described in United States patent 4,530,586 provided with electromagnetically actuated solenoids and zero dead volume were connected in a modular fashion providing multiple input to a single output line.

The valves which control the flow of reagents and solvents are computer operated pursuant to a program appropriate for the chemistry involved.

Example 1 Sequencing of Leucine Enkephalin (YGGFL) (1.2 nmoL) Covalently Coupled to PVDF The thiohydantoin amino acid derivatives were separated by reverse phase HPLC. This separation was performed on Phenomenex Ultracarb 5 ODS(30) column mm x 25 mm) on a Beckman System Gold with a Shimadzu (SPD-6A) detector. The column was eluted for 2 min with solvent A trifluoroacetic acid in water) and then followed by a discontinuous gradient to solvent B (80% acetonitrile, 10% methanol

L

SWO 91/18008 PCT/US90/0:723 in water) at a flow rate of 0.15 mL/min at 22°C. The gradient uied was as follows: 0% B for 2 min, 0-6% B over 3 min, 6-35% B over 35 min, 35-50% B over min, and 50-0% B over 10 min.

STable 1 i Composition of Reagents and Solvents R1 Acetic anhydride R2 30% TMS-ITC in acetonitrile R3 0.05 M Sodium trimethylsilanolate in 2-trimethylsilylethanol R4 Methanol Sl Acetonitrile S2 0.8% Trifluoroacetic acid in water S3 Methanol S4

A_

~u Table 2 C-Terminal Sequencer Program Summary Continuous Flow Conversion Duration Total Time Reactor (CFR)(70°C) Flask (CF)(50* C) (min) (min) Dry Dry 3.0 R1 reaction 5.0 R1 reaction 5.0 13.0 S1 rinse 0.5 13.5 R2 reaction 10.0 23.5 S1 rinse 1.0 24.5 R2 reaction 10.0 34.5 S1 rinse 1.0 35.5 R2 reaction 10.0 45.5 S3 rinse 1.0 46.5 S1 rinse 1.0 47.5 Sl rinse 1.0 48.5 S1 rinse 1.0 49.5 R3 reaction 10.0 59.5 R3 to CF 0.5 60.0 Dry 10.0 70.0 R4 delivery 0.2 70.2 Dry 8.3 78.5 R4 delivery 0.2 78.7 Dry 8.3 87.0 S2 delivery 0.1 87.1 S2 reaction 0.5 87.6 S2 to CF 0.5 88.1 S2 delivery 0.1 88.2 S2 reaction 0.5 88.7 S2 to CF 0.5 89.2 inject 1.0 90.2 S3 rinse 1.0 91.2 S1 rinse 1.0 92.2 S1 rinse 1.0 93.2 Sl rinse 1.0 94.2 R4 rinse 1.0 95.2 I II Li ;I.

WO 91/18008 PCr/US90/02723 -12- Figure 3 depicts the HPLC analysis of products of the reaction.

Example 2 Sequencing of KVILF (1.2 nmoL) Covalently Coupled to PVDF The thiohydantoin amino acid derivatives were separated by reverse phase HPLC. This separation was performed on Phenomenex Ultracarb 5 ODS(30) column mm x 25 mm) on a Beckman System Gold with a Shimadzu (SPD-6A) detector. The column was eluted for 2 min with solvent A trifluoroacetic acid in water) and then followed by a discontinuous gradient to solvent B (80% acetonitrile, 10% methanol in water) at a flow rate of 0.15 mL/min at 22*C. The gradient used was as follows: 0% B for 2 min, 0-6% B over 3 min, 6-35% B over 35 min, 35-50% B over min, and 50-0% B over 10 min.

Table 3 Composition of Reagents and Solvents R1 Acetic anhydride R2 30% TMS-ITC in acetonitrile R3 0.05 M Sodium trimethylsilanolate in methanol R4 Methanol S1 Acetonitrile S2 0.8% Trifluoroacetic acid in water .1

Y

Table 4 C-Terminal Sequencer Program Summary Continuous Flow Conversion Duration Total Time Reactor (CFR)(70C) Flask (CF)(50° C) (min) (min) Dry Dry 3.0 R1 reaction 5.0 R1 reaction 5.0 13.0 S1 rinse 0.5 13.5 R2 reaction 10.0 23.5 Sl rinse 1.0 24.5 R2 reaction 10.0 34.5 S1 rinse 1.0 35.5 R2 reaction 10.0 45.5 S1 rinse 1.0 46.5 Sl rinse 1.0 47.5 S1 rinse 1.0 48.5 R3 reaction 5.0 53.5 R3 to CF 0.5 54.0 Dry 3.0 57.0 R4 delivery 0.2 57.2 Dry 5.0 62.2 S2 delivery 0.1 62.3 S2 reaction 3.0 65.3 S2 to CF 0.5 65.8 S2 delivery 0.1 65.9 S2 reaction 3.0 68.9 S2 to CF 0.5 69.4 inject 1.0 70.4 S1 rinse 1.0 71.4 Sl rinse 1.0 72.4 S1 rinse 1.0 73.4 R4 rinse 1.0 74.4 ~nn~- WO 91/18008 PCT/US90/02723 -14- Figure 4 depicts the HPLC analysis of the products of the reaction.

Claims (7)

1. A method for sequencing a peptide by carboxyl terminal degradation which comprises coupling the carboxyl terminus of a peptide with a silyl isothiocyanate coupling reagent to form a peptidylthiohydantoin derivative and cleaving the peptidylthiohydantoin derivative with sodium trimethylsilanolate to provide a thiohydantoin derivative of the amino acid previously at the carboxyl terminus of a peptide and a peptidyl residue lacking such an amino acid.

2. The method as defined by claim 1 in which the peptide is coupled to a polyvinyldifluoride or a polyethylene membrane.

3. A method as defined by claim 1 or claim 2 in which said cleaving of said peptidylthiohydantoin is conducted in a solvent selected from the group consisting of alkanols having from 1 to about 4 carbon atoms and trimethylsilylethanol.

4. A method as defined by claim 1 or claim 2 in which said silylisothiocyanate is trimethylsilylisothiocyanate. A method for sequencing a peptide by carboxyl terminal degradation which comprises coupling the carboxyl terminus of a peptide with a silyl isothiocyanate coupling reagent to form a peptidylthiohydantoin derivative and cleaving the peptidylthiohydantoin derivative with a reagent having the formula R3Sio-X in which R is a straight or branched chain hydrocarbon radical having from about 1 to about 10 carbon atoms and X is an alkali metal ion to provide a thiohydantoin derivative of the amino acid previously at the carboxyl terminus of a peptide and a peptidyl residue lacking such an amino acid.

WO 91/18008 PCT/US90/02723 -16-

6. The method as defined by claim 5 in which the peptide is coupled to a polyvinyldifluoride or polyethylene membrane.

7. A method for sequencing a peptide by carboxyl i terminal degradation which comprises coupling the carboxyl terminus of a peptide with a coupling reagent to form a peptidylthiohydantoin derivative and cleaving the peptidylthiohydantoin derivative Iwith a reagent having the formula R 3 SioX in which R is a straight or branched chain hydrocarbon radical having from about 1 to about 10 carbon atoms and X is an alkali metal ion to provide a thiohydantoin derivative of the amino acid previously at the carboxyl terminus of a peptide and a peptidyl residue lacking such an amino acid. !I ia